| Name | Title | Contact Details |
|---|
Interstate Blood Bank Inc is a Memphis, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Trinity Health - New England is an integrated health care delivery system comprised of world-class providers and facilities dedicated to the full spectrum of preventive, acute, and post-acute care, all delivered with the triple aim of better health, better care, and lower costs for our patient populations. In New England, our hospitals, walk-in clinics, medical offices, specialized facilities, affiliated institutions, and foundations serve a population of nearly 3 million people. As a dynamic part of Trinity Health, based in Livonia, Michigan, and one of the nation`s largest multi-institutional Catholic health care delivery systems, Trinity Health - New England is uniquely positioned to advance health care through alliances with the University of Connecticut School of Medicine, the Frank H. Netter MD School of Medicine at Quinnipiac University, and through our own research institutions dedicated to the development of primary care, new treatments for cancer and MS, and much more.
SAFECOR HEALTH LLC is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Mesa, AZ. To find more information about SAFECOR HEALTH LLC, please visit www.safecorhealth.com
Network Foundations is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.